Most of us experience healthcare from the consumer side of the equation. We see the doctor, get the prescription, pay the bill, go home and move on.
We rarely think about what it takes to make that system work behind the scenes. Or at least what happens when the economics stop working.
Today, we’re taking a closer look at that less visible side of healthcare through UnitedHealth Group (UNH) CFO Wayne DeVeydt’s discussion of the company’s latest deal.
Some phrases seem almost too casual for Wall Street, especially when they come from a top executive. DeVeydt made one such comment while discussing UnitedHealth’s deal, and it revealed far more than the transaction itself.
UnitedHealth sold an interest in some of its Florida-based Optum Health operations to private equity firm TPG on Sep. 9, Bloomberg reported. And the CFO’s explanation offered a glimpse into how the healthcare goliath is thinking about capital, its portfolio and what comes next.
“We didn’t need the dollars; we have the dollars to invest, but we needed the focus and somebody that could actually work with us locally,” DeVeydt told Bloomberg.
The Florida facilities belong to Optum’s WellMed division, which serves senior citizens and operates value-based care clinics. This is a restructuring move by the health king, amid one of the most consequential turnarounds in American healthcare over the past 16 months or so.
UNH trades near $379.09, up 16.39% year-to-date, according to Yahoo Finance. The 1-year return is now at 10.08%.
What went wrong at Optum and how the reset is progressing
To fully understand this deal, we need to go back to last year’s collapse.
Optum Health, the medical clinic arm of UnitedHealth’s services business, ran into a wall of rising healthcare costs and restrictive federal Medicare Advantage payment policies. That pushed operating margins firmly into negative territory. And, of course, there were consequences.
In fact, severe ones because UnitedHealth’s earnings collapsed, leadership was replaced, and the entire Optum strategy came under intense scrutiny.
More Healthcare Coverage:
- Mark Cuban warns AI could make US healthcare even worse
- Medicaid’s 5-year rule catches families off guard
- GLP-1 weight-loss drug popularity reaches new heights with Americans
CEO Andrew Witty stepped down and was replaced by former CEO Stephen Hemsley, who had run the company through an earlier period of growth. Wayne DeVeydt was brought in as CFO, replacing John Rex. Optum Health leadership was also reshuffled.
UnitedHealth reported in its previous earnings report that it intentionally served approximately 700,000 fewer value-based care patients year over year as it recentered on higher-quality, integrated care relationships.
I think the restructuring is working, at least on the margin trajectory DeVeydt described. Optum Health margins reached approximately 2% in 2026, exceeding earlier forecasts. He projects approximately 4% in 2027 and 6% in 2028, the CFO noted in a Bloomberg interview.
We can clearly see the progression from deeply negative to low single digits to mid-single digits.
Why TPG? And what does the ‘focus’ comment really mean?
The choice of TPG as a partner is intentional. TPG is a healthcare-specialized private equity firm that previously acquired Optum U.K. earlier this year, generating $400 million for the UnitedHealth Foundation.
This is an established relationship. Bringing TPG into the Florida WellMed operations gives those clinics a no-nonsense owner who can work locally and move quickly.
Optum Health CEO Krista Nelson confirmed at the Wells Fargo healthcare investor conference on Sep. 9 that the TPG transaction aligns with Optum’s disclosed restructuring plan and that similar strategic partnerships are being executed across several additional healthcare markets.
Related: UnitedHealth CFO sends stark warning after earnings
DeVeydt’s “we needed the focus” is an honest admission that elephants of the house sometimes hold on to businesses they are not optimally positioned to run.
The WellMed clinics in Florida serve seniors in value-based care arrangements that require local relationships, local knowledge, and management attention that a company executing a national turnaround cannot always provide at the margin level needed to make the economics work. So, bringing in a specialized partner can take on that local focus.
The UNH dividend aristocrat runs quietly in the background
UNH is a Dividend Aristocrat. It’s one of a select group of companies that have raised their dividend every year since 1990, according to UNH dividend history data.
The most recent quarterly dividend of $2.32 per share was announced with an ex-dividend date of Sep. 14, 2026, payable next Tuesday, Sep. 22. Yahoo Finance reports that the trailing 12-month dividend yield is 2.36%, and the forward yield is 2.45%, shows expected continued increases.
Also Read: How many employees does UnitedHealth have? Its workforce, locations & layoffs explained
The ten-year annual dividend growth rate stands at 16.70%. Over five years, the compound annual growth rate was 12.80%. The five-year yield on cost for investors who bought UNH shares five years ago is approximately 4.31%.
Remember, the business has paid shareholders and kept raising dividends through crises, leadership changes, and margin collapses.
Q2 fiscal 2026 Optum Health revenues of $23.5 billion were down 5% year over year. That reduction was expected due to the deliberate value-based care service. The operating income of $1.2 billion, with a 5.1% margin, is the most visible improvement since the collapse began.
Full-year 2026 adjusted operating earnings guidance greater than $2.215 billion further confirms management’s visibility into the trajectory.
At $379 and with a 36-year dividend growth streak, a CFO who says the capital position is strong, margins recovering toward 6% in 2028, and a focused restructuring that brought TPG in to run the hardest-to-manage piece, I think UnitedHealth looks more like they’re working through a known problem than one facing an existential one.
Related: UnitedHealth’s earnings comeback hides a risk Wall Street can’t price
